Article
Phenotype-based screening of mechanistically annotated compounds in combination with gene expression and pathway analysis identifies candidate drug targets in a human squamous carcinoma cell model.
Journal of biomolecular screening - 1 Aug 2006
Fryknäs Mårten, Rickardson Linda, Wickström Malin, Dhar Sumeer, Lövborg Henrik, Gullbo Joachim, Nygren Peter, Gustafsson Mats G, Isaksson Anders, Larsson Rolf
Abstract excerpt
The squamous cell carcinoma HeLa cell line and an epithelial cell line hTERT-RPE with a nonmalignant phenotype were interrogated for HeLa cell selectivity in response to 1267 annotated compounds representing 56 pharmacological classes. Selective cytotoxic activity was observed for 14 of these compounds dominated by cyclic adenosine monophosphate (cAMP) selective phosphodiesterase (PDE) inhibitors, which tended to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
